Evolent Health, Inc. (EVH): Board Co Advisory , 10% owner of Evolent Health, Inc. sold 317,712 shares on Sep 22, 2016. The Insider selling transaction was reported by the company on Sep 22, 2016 to the Securities and Exchange Commission. The shares were sold at $22.50 per share for a total value of $7,148,520.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 16, 2016, Upmc (10% owner) sold 2,460,307 shares at $21.54 per share price.On Sep 15, 2016, Steve Wigginton (Chief Development Officer) sold 45,760 shares at $21.54 per share price.Also, On Sep 15, 2016, Jonathan Weinberg (General Counsel) sold 10,339 shares at $21.54 per share price.On Sep 15, 2016, Dave Thornton (Chief Talent Officer) sold 18,393 shares at $21.54 per share price.
Shares of Evolent Health Inc (EVH) ended Tuesday, Sep 21, 2016 session in red amid volatile trading. The shares closed down -0.24 points or -1.06% at $22.47 with 2,79,292 shares getting traded. Post opening the session at $22.85, the shares hit an intraday low of $21.95 and an intraday high of $22.92 and the price vacillated in this range throughout the day. The company has a market cap of $1,353 M and the number of outstanding shares has been calculated to be 6,02,09,997 shares. The 52-week high of Evolent Health Inc is $26.8392 and the 52-week low is $8.14.
Company has been under the radar of several Street Analysts.Evolent Health Inc is Reiterated by FBR Capital to Outperform and the brokerage firm has raised the Price Target to $ 26 from a previous price target of $24 .The Rating was issued on Aug 5, 2016.Evolent Health Inc is Initiated by Jefferies to Buy. The Rating was issued on Jul 26, 2016.Evolent Health Inc is Reiterated by FBR Capital to Outperform and the brokerage firm has raised the Price Target to $ 24 from a previous price target of $16 .The Rating was issued on Jul 13, 2016.
Evolent Health Inc. is engaged in the healthcare delivery and payment markets. The Company’s platform enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to value-based payment models. It provides an end-to-end technology-enabled services platform for providers to transition their organization in value-based payment models. It markets and sells services to providers throughout the United States. The Company works with its partners in two phases. In the transformation phase it works with its partners to develop a plan for their transition to a value-based care model. During the second portion of the transformation phase the Company works with its partner to implement the Blueprint. During the transformation phase the Company seeks to enter into long-term agreements with its partners. In the platform and operations phase the Company establishes a local market presence and embeds its resources alongside the Company’s partners.